Glioblastoma drug resistance pathway identified Neurology News
Summary: Researchers have identified a key signaling pathway, PI3K-beta, responsible for chemotherapy resistance in glioblastoma. Blocking this pathway makes tumor cells more sensitive to temozolomide, a standard chemotherapy drug. This…